Lantheus Holdings (LNTH) Total Current Liabilities (2014 - 2026)

Lantheus Holdings (LNTH) reported Total Current Liabilities of $333.2 million for Q1 2026, up 34.34% year-over-year from $248.0 million in Q1 2025, and little changed quarter-over-quarter from $333.4 million in Q4 2025.

Lantheus Holdings (LNTH) Total Current Liabilities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Total Current Liabilities data on file, last reported at $333.2 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $333.2 million, up 34.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $333.2 million (up 34.34% YoY), and the FY2025 annual result was $333.4 million, up 38.62% from the prior year.
  • Total Current Liabilities steadied at $333.2 million in Q1 2026 per LNTH's latest filing, from $333.4 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $784.1 million in Q3 2024 and troughed at $154.0 million in Q2 2023.
  • A 5-year average of $278.9 million and a median of $247.7 million in 2022 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities surged 343.98% in 2024, then plunged 55.76% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $247.7 million in 2022, then decreased by 24.36% to $187.4 million in 2023, then rose by 28.38% to $240.5 million in 2024, then jumped by 38.62% to $333.4 million in 2025, then retreated by 0.08% to $333.2 million in 2026.
  • Business Quant data shows LNTH's Total Current Liabilities at $333.2 million in Q1 2026, $333.4 million in Q4 2025, and $346.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 13.53 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 2.05 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 831.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 1.66 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 599.50 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 333.17 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 618.78 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 149.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 333.17 Mn
Dec 31, 2025 333.42 Mn
Sep 30, 2025 346.84 Mn
Jun 30, 2025 280.13 Mn
Mar 31, 2025 248.00 Mn
Dec 31, 2024 240.53 Mn
Sep 30, 2024 784.08 Mn
Jun 30, 2024 263.29 Mn
Mar 31, 2024 237.20 Mn
Dec 31, 2023 187.35 Mn
Sep 30, 2023 176.60 Mn
Jun 30, 2023 154.04 Mn
Mar 31, 2023 276.39 Mn
Dec 31, 2022 247.70 Mn
Sep 30, 2022 235.98 Mn
Jun 30, 2022 219.02 Mn
Mar 31, 2022 177.66 Mn
Dec 31, 2021 90.50 Mn
Sep 30, 2021 76.90 Mn
Jun 30, 2021 73.83 Mn